Acerta Pharma, in close collaboration with AstraZeneca, takes an innovative approach to discover, develop and deliver targeted novel transformational medicines for patients with …

Acerta Pharma is a European R&D centre of the AstraZeneca Group, based in the Netherlands, dedicated to the discovery and development of novel innovative medicines for the treatment of …

Working together, Acerta and AstraZeneca are focused on Innovative Clinical Strategies to enable us to combine our extensive oncology portfolio of cancer therapies as well as combinations …

1 Covey T, et al. Presentation at the 2015 annual AACR meeting. Abstract 2596. 2 Byrd JC, et al. N Engl J Med. 2016;374(4):323-332.

Acerta Pharma, in close collaboration with research groups in AstraZeneca, takes an innovative approach to discover, develop and deliver targeted novel transformational medicines for …

Early access to Acerta Pharma medicinal products We recognize that there are circumstances where patients with serious or life-threatening diseases have exhausted all available …

Acerta Pharma is motivated to work with those who share our desire to understand tumor biology and drug resistance mechanisms. Besides resistance to BTK inhibitors, we believe the BPACS …

Acerta Pharma has applied its expertise in covalent technology to the selective targeting of BTK while minimizing inhibition of non-BTK kinases.

Whatever your position is at Acerta Pharma, working here means helping to improve the health of millions of people. Do you want to learn more about working at Acerta Pharma? Our …